Related Experiment Video

Updated: Jul 2, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Reversible regulation of metastasis by ROS-generating mtDNA mutations

Kaori Ishikawa1, Nobuko Koshikawa, Keizo Takenaga

  • 1Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan; Japan Society for the Promotion of Science (JSPS), 8 Ichiban-cho, Chiyoda-ku, Tokyo 102-8472, Japan.

Mitochondrion
|August 30, 2008
PubMed

Insights

Mitochondrial DNA (mtDNA) mutations reversibly control cancer metastasis, not tumor formation, by affecting reactive oxygen species (ROS). This suggests ROS scavengers could treat metastatic cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Genetics

Background:

  • The role of mitochondrial DNA (mtDNA) mutations in cancer development and progression remains controversial.
  • Understanding the specific mechanisms by which mtDNA influences tumor behavior is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the direct role of mtDNA mutations in oncogenic transformation and malignant progression.
  • To elucidate the functional impact of specific mtDNA mutations on cancer metastasis.

Main Methods:

  • Creation of trans-mitochondrial cybrids by exchanging mtDNA between mouse tumor cells with distinct metastatic potentials.
  • Analysis of the G13997A mutation in the ND6 gene of mtDNA and its correlation with metastatic phenotypes.

Main Results:

  • A specific mtDNA mutation (G13997A in ND6) was found to reversibly control the development of metastases.
  • This metastatic control was mediated by the overproduction of reactive oxygen species (ROS).
  • The identified mtDNA mutation did not influence the initial development of tumors (oncogenic transformation).

Conclusions:

  • Mitochondrial DNA plays a critical, reversible role in controlling cancer metastasis, distinct from tumor initiation.
  • Overproduction of ROS due to mtDNA mutations is a key mechanism driving metastasis.
  • Targeting ROS pathways with scavengers presents a potential therapeutic strategy for suppressing cancer metastasis.

More Related Videos

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...